FDA Product Code DXT: Injector And Syringe, Angiographic
Leading manufacturers include Medrad, Inc., Osprey Medical, Inc. and Coeur, Inc..
FDA 510(k) Cleared Injector And Syringe, Angiographic Devices (Product Code DXT)
About Product Code DXT - Regulatory Context
510(k) Submission Activity
210 total 510(k) submissions under product code DXT since 1978, with 210 receiving FDA clearance (average review time: 146 days).
Submission volume has increased in recent years - 8 submissions in the last 24 months compared to 4 in the prior period - suggesting growing market activity in this device classification.
FDA 510(k) Review Time - DXT Product Code
Recent submissions under DXT have taken an average of 228 days to reach a decision - up from 143 days historically. Manufacturers should account for longer review timelines in current project planning.
DXT devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →